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An integrated chronic disease management (ICDM) model was introduced by the National
Department of Health in South Africa to tackle the dual burden of HIV/AIDS and non-com-
municable diseases. One of the aims of the ICDM model is to reduce HIV-related stigma.
This paper describes the viewpoints of service users and providers on HIV stigma in an
ICDM model in rural South Africa.
Materials and methods
A content analysis of HIV stigmatisation in seven primary health care (PHC) facilities and
their catchment communities was conducted in 2013 in the rural Agincourt sub-district,
South Africa. Eight Focus Group Discussions were used to obtain data from 61 purposively
selected participants who were 18 years and above. Seven In-Depth Interviews were con-
ducted with the nurses-in-charge of the facilities. The transcripts were inductively analysed
using MAXQDA 2018 qualitative software.
Results
The emerging themes were HIV stigma, HIV testing and reproductive health-related con-
cerns. Both service providers and users perceived implementation of the ICDM model may
have led to reduced HIV stigma in the facilities. On the other hand, service users and
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providers thought HIV stigma increased in the communities because community members
thought that home-based carers visited the homes of People living with HIV. Service users
thought that routine HIV testing, intended for pregnant women, was linked with unwanted
pregnancies among adolescents who wanted to use contraceptives but refused to take an
HIV test as a precondition for receiving contraceptives.
Conclusions
Although the ICDM model was perceived to have contributed to reducing HIV stigma in the
health facilities, it was linked with stigma in the communities. This has implications for prac-
tice in the community component of the ICDM model in the study setting and elsewhere in
South Africa.
Background
The high dual burden of chronic non-communicable diseases (NCDs) and HIV/AIDS typifies
South Africa’s epidemiological transition [1] which has implications for its health system.
Globally, hypertension is the key risk factor for cardiovascular diseases [2] which in turn are
the leading cause of mortality due to NCDs. It is estimated that 43% of South African adults
are hypertensive [3] and nearly 50% of all deaths in South Africa are due to NCDs [4].
Similarly, the Human Immune-deficiency Virus (HIV) prevalence in South Africa was esti-
mated at 13.1% in 2018, one of the highest in Africa [5]. Approximately 7.52 million people
lived with HIV in 2018, with adults 15–49 years having a higher prevalence of 19% than the
general population [5]. The HIV burden in South Africa is unequal by race, age and sex. The
prevalence in black populations is 40–50 times that of white [6] and age-adjusted HIV preva-
lence differs significantly between women (26%) and men (19%) [7]. In adolescents, the risks
of infection are eight times higher in females than males [6]. One of the main challenges People
Living with HIV (PLWH) face is stigmatisation which is considered to occur at three levels:
enacted, anticipated and internalized. Enacted stigma occurs when PLWH believe they experi-
ence prejudice and discrimination [8, 9]. Anticipated stigma happens when PLWH have an
expectation that they will experience prejudice and discrimination [10]. Internalized stigma
refers to a situation where PLWH endorse the negative beliefs and feelings linked with HIV/
AIDS [9].
These forms of stigma are linked with negative health outcomes. Enacted and internalized
stigma have been linked with increased prevalence of mental health disorders in different set-
tings [11–13], particularly depression [14, 15] and anxiety [16, 17]. South African adults who
experience high levels of internalized stigma have been reported to be less help-seeking and
show signs of post-traumatic stress disorder [18]. Another study in South Africa showed that
anticipated stigma was a barrier to care. Although PLWH reported less enacted stigma or hos-
tility, they felt that HIV was synonymous with promiscuity and infidelity [19]. HIV stigmatisa-
tion could negatively impact achievement of the zero discrimination and 95-95-95 (i.e. 95% of
people who live with HIV knowing their status, 95% of people who know their status receiving
treatment and 95% of people on HIV treatment having a suppressed viral load) targets of end-
ing the HIV/AIDS epidemic by 2030 in the context of the Sustainable Development Goals
(SDGs) [20].
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It is feasible to tackle the burden of HIV/AIDS and NCDs due to the commonalities in their
prevention, management and control [21]. For instance, HIV and many NCDs have minimal
or no symptoms at early stages of onset; thus, requiring a model of care different from acute
care model. Next, both conditions require ongoing clinic appointments and adherence; hence,
the need for approaches that entail appropriate appointment and medication reminder sys-
tems, adherence, self-management and referrals [22]. Furthermore, antiretroviral treatments
(ARTs) increase the risk of lipidaemia and diabetes due to physiological mechanisms. This
implies that PLWH and who are on ART have an increased chance of developing NCDs from
three sources: first, from HIV infection itself; second, from ARTs; and third, from increasing
age [23].
Early evidence showing the feasibility of integrating HIV/AIDS and NCD care emerged
from a pilot study in Cambodia [24]. The findings showed that: 57% of diabetes patients had
their glycosylated haemoglobin values equal to or less than the target of 9%, nearly 70% of
hypertension patients on regular treatment for more than six months had their blood pressure
values equal to or below the target of 160/90 mmHg and the median CD4 count of PLWH
increased from 53 cells/mm3 at baseline to 316 cells/mm3 at the end of the second year of treat-
ment. Furthermore, the same study showed that an integrated care for HIV/AIDS, hyperten-
sion and diabetes had a positive effect on HIV/AIDS-related stigma [24].
The pilot programme in Cambodia demonstrated the feasibility of providing an integrated
care in the same clinic without HIV stigma being an obstacle to access to services. In view of
the evidence in South Africa that HIV stigma is a barrier to care [19] and PLWH experience
high levels of internalized stigma and are, therefore, less help-seeking [18], lessons learnt from
the Cambodia study could serve as an impetus to reduce HIV stigma in South Africa.
To reduce HIV stigmatisation and improve patient health outcomes in South Africa [1, 25],
the National Department of Health in 2011 introduced an Integrated Chronic Disease Manage-
ment (ICDM) model as a pilot intervention programme in primary health care (PHC) facilities
using the health systems approach [26, 27]. The purpose of the ICDM model of care is to leverage
the HIV vertical programme to support or scale up services for NCDs to reduce HIV stigmatisa-
tion and to improve health outcomes of patients with NCDs [24]. The model has a facility com-
ponent in which facilities are reorganised to enable providers to offer services for HIV and
NCDs in a ‘one-stop-shop’ in designated chronic care areas. The community component of the
model has a PHC outreach team comprising a nurse and community healthcare workers who
visit patients’ homes to provide home-based care and link clinic defaulters back to care [28].
Other than the Cambodian study [24], other studies exploring integrated models of care
have also been reported in Uganda [29], Malawi [30] and Kenya [31]. However, little is known
about HIV stigmatisation in the context of the ICDM model of care using a qualitative inquiry.
The aim of this research was to assess HIV stigma from the viewpoints of service users and
providers in a rural setting in South Africa.
Materials and methods
Study site
The site for this study was in the Agincourt sub-district, Mpumalanga Province, South Africa.
During commencement of data collection (November and December 2013), ICDM was being
implemented in 17 of the 38 PHC facilities in the municipality. Seven of the 17 PHC facilities
were selected because they are situated in the Ehlanzeni health district where the Medical
Research Council/Wits Agincourt Research Unit has surveyed the population since 1992 using
a Health and Demographic Surveillance System (HDSS). The population under surveillance in
the Agincourt HDSS is 90,000 people in 16,000 households living in 27 villages [32].
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Study design and population
This is a content analysis of the ICDM model implemented in PHC facilities and their catch-
ment communities. It was a part of a broader mixed methods research project which evaluated
the quality of care in the ICDM model [33, 34] in the study setting. The study population con-
sisted of patients 18 years and above being managed for HIV, hypertension or diabetes in the
seven PHCs in the sub-district. The facility managers (i.e. professional nurses-in-charge of the
seven facilities) were also considered part of the study population because of their viewpoints
as service providers and facility managers.
Inclusion and exclusion criteria
Patients diagnosed with and being managed in the health facilities for either HIV or hyperten-
sion or diabetes were eligible to participate in the study. Inclusion criteria were being on treat-
ment six months before the ICDM model was implemented, participating in the health facility
quantitative exit interviews on quality of the ICDM model of care commenced in June 2013
[33], overwhelmingly reporting (dis)satisfaction in the exit interviews and willingness to par-
ticipate in the current Focus Group Discussions (FGDs). The quantitative survey, which pre-
ceded the qualitative study, was a cross-sectional survey of patients who were interviewed in
the health facilities after consultations with the nurses (patient exit interviews). The survey was
designed to contribute to understanding the quality of care in the ICDM model. The managers
of the seven health facilities in the district were purposively selected for the In-depth Inter-
views (IDIs) based on their depth of experience as service providers and facility managers.
Data collection
The quantitative exit interviews provided a large sampling frame from which purposive selec-
tion of prospective participants for the FGDs was done to explore patients’ in-depth perspec-
tives on the dimensions of quality of care in the ICDM model. These dimensions of care were
the pre-identified (a priori) topics in the qualitative component [34] of the boarder mixed
methods research earlier described. During the exit interviews of the 435 randomly selected
patients [33], which were held during the official clinic working hours (8.00 am—4.30 pm
local time) from Monday to Friday, 80 patients who met the inclusion criteria described above
were briefed about the purpose of the study and scheduled dates of the discussions and invited
for the FGDs. Of these 80 purposively selected patients, 61 men and women participated in
eight FGDs (i.e. one FGD per health facility and one FGD for clinic defaulters, defined in this
study as HIV or hypertension or diabetes patients who missed three or more consecutive clinic
appointments as was observed through the review of clinic records). Although stigma is a
highly personal issue which could have been better discussed individually and with a wide
range of people, HIV stigma can be and has been explored using FGDs in South Africa [19,
35], East Africa [36, 37] and the United States of America [38].
Two qualitative fieldworkers conducted the FGDs with 5–9 participants of similar age with
each session lasting 60–90 minutes. Using the FGD guide written in English (S1 File), the
more senior fieldworker moderated the discussions in Tsonga language by translating the
guide from English to Tsonga during the discussions, while the second fieldworker audiotaped
the discussions and made field notes during and after the FGDs.
Seven IDIs were conducted with the nurses-in-charge of the seven health facilities who
were all females. The Principal Investigator (PI, S.A.) conducted and audiotaped the IDIs with
the facility managers in English using the IDI guide (S2 File) which contained the same topics
as the FGD guide. The IDIs were held in the offices of the facility managers during lunch break
with an average duration of 30 minutes. The FGDs for service users and IDIs for facility
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managers were held concurrently. It was not possible to conduct FGDs for the facility manag-
ers at a convenient time and venue because of the nature of their busy work schedule.
Quality assurance
The PI did a two-day training session with two senior qualitative field workers who had
worked in the Agincourt HDSS for at least 10 years. The PI briefed field workers about the
purpose of the study and discussions were held on how to administer the semi-structured
topic guide and facilitate the discussions encouraging participation and balanced coherent dis-
cussion. The topic guides for the FGDs and IDIs were developed from the validated multi-
scale Patient Satisfaction Questionnaire-18 (S3 File) which was developed by Ware et al. to
assess dimensions of patient satisfaction with quality of care [39]. The interview guides were
pretested in another community outside the study setting. The audio recordings of the FGDs
were translated and transcribed into English by the two qualitative field workers. A third quali-
tative field worker, who was blinded to the other two field workers, validated the transcriptions
by listening to two of the eight audiotapes and translating them into English. There were no
major differences between the first and second transcriptions. A similar procedure was used to
assure data quality for the IDIs.
Efforts were made to address trustworthiness of the data. Credibility of the data was
enhanced by triangulating the data through administration of the same questions in the topic
guides to different categories of participants: FGD guide to the participants and in-depth inter-
view guide to the facility managers. For the purpose of transferability of the study findings, a
description of the participants and the research process was provided to enable a reader transfer
the findings of this research to their settings [e.g. context in which the research was carried out
(PHC facilities implementing the ICDM model), its setting (rural), sample (61 participants),
sample strategy (80 purposively sampled prospective participants), demographic and socio-eco-
nomic characteristics (black rural male and female participants from a generally low socio-eco-
nomic background), inclusion and exclusion criteria, interview procedure and topics and
excerpts from the interview guide] [40]. Furthermore, prospective FGD participants of similar
age were recruited from the seven PHC facilities during clinic opening hours on week days. The
purpose of selecting participants of similar age was to enable in-depth exploration, of lived expe-
riences with quality of care capitalising on group interactions. The FGDs were held on Satur-
days at a convenient time for most of the prospective participants and in generally centrally
located designated venues within the catchment communities served by the seven health facili-
ties. The FGDs were held outside facilities to encourage participants to freely express and com-
municate their experiences without fear of intimidation or victimisation. Concerns of
dependability and reliability of the data via coding and verification of inconsistent codes are
presented under the Data Analysis sub-section below. Overall, eight FGDs and seven IDIs were
conducted and more could not be done because data saturation was achieved, as was done else-
where in South Africa where eight FGDs were conducted for 41 participants [35].
Although the transcripts were not returned to the participants for comments and/or correc-
tions, the moderator of the FGDs and interviewer of the facility managers summarised the dis-
cussions and interviews to the participants who were requested to identify missing
information or gaps.
Data analysis
The transcribed FGDs and IDIs were thematically analysed using MAXQDA 2018 qualitative
software. The emerging theme on HIV stigma, HIV testing and reproductive health-related
concerns were inductively analysed (i.e. the HIV stigma theme emerged as a new code not
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originally included in the coding framework). The analysis process began with multiple read-
ings of the transcripts to allow themes unrelated to those in the topic guide to emerge. The PI
coded the data through an iterative process and developed a codebook which was based on the
recurring emerging themes. Interesting features in the texts were highlighted and dragged to
the generated codes to reflect the meanings in the segments of the transcript. Each code and its
texts were assigned the same colour to distinguish one code from another. Thereafter, some
codes were grouped together in a hierarchical manner, like a coding tree, to form an overarch-
ing theme. The co-authors verified the codes through the reading and re-reading of the quotes,
interrogated the data by discussing inconsistent codes and developed consensus on the emerg-
ing themes. This paper focuses on the emerging themes from the topics on quality of care in
the ICDM model discussed in the FGDs and IDIs (Fig 1), while analysis of the 17 pre-identi-
fied (a priori) topics on quality of care (Fig 2) have been published elsewhere [34].
Research team and reflexivity
The corresponding author and Principal Investigator (PI), SA, has over 20 years of experience
in medical practice and 15 years of experience in conducting medical research. He attended
organised courses on qualitative methods specifically to equip and prepare him to conduct this
study. His published qualitative article on the 17 pre-identified themes on quality of care in the
ICDM model was ranked 4th among the 10 most cited articles in Health Policy and Planning
Journal in 2019 (http://blogs.lshtm.ac.uk/hppdebated/2020/02/19/health-policy-and-
plannings-top-10-articles-in-2019/).
The two senior qualitative fieldworkers were well known to the members of the communi-
ties where the study was conducted because they come from, live and work in these communi-
ties. Before the interviews and FGDs were conducted, the study team was introduced to the
participants and the purpose of the study was explained to them. These details were in the
information sheets which were given to the participants as their personal copies. One of the
co-authors, LD, a female social scientist and a qualitative researcher at the Institute of Applied
Health Sciences and Centre for Sustainable International Development University of Aber-
deen, UK, supported the study team with technical expertise in the study design, conduct of
the study, interpretation of the findings and drafting of the manuscript.
No biases or assumptions were reported about the interviewers. However, the interest of
the research team and the purpose of the study was to get an in-depth perspective of health ser-
vice users and providers on the quality of care in the ICDM model for the purpose of providing
feedback to the managers of the ICDM model. After the study was conducted, a policy brief
was submitted to the Mpumalanga Provincial Department of Health and the School of Public
Health, University of the Witwatersrand, Johannesburg, South Africa.
All authors have a PhD degree: SA, FXGO, KK an ST are medical doctors, senior research-
ers, epidemiologists, public health scientists and university lecturers; LD is a social scientist,
senior researcher and university lecturer; and KKG is an epidemiologist, a senior researcher
and university lecturer.
The Agincourt Unit is a world class research centre which attracts researchers from aca-
demic institutions from all over the world. The unit has over twenty years of established rela-
tionship with the communities where the study participants live as well as the Provincial
Department of Health who were aware of the study.
Ethics statement
All procedures performed in studies involving human participants were in accordance with
the ethical standards of the institutional and/or national research committee (University of the
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Witwatersrand, Johannesburg (M120943) and the Mpumalanga Provincial Research and Eth-
ics Committee, South Africa.) and with the 1964 Helsinki declaration and its later amend-
ments or comparable ethical standards. These Ethics Committees specifically approved this
study. Written informed consent for the interviews/discussions and audio recordings were
Fig 1. Schematic overview of the emerging themes from topics discussed in the focus groups and interviews.
https://doi.org/10.1371/journal.pone.0236270.g001
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obtained from all individual participants in the study. These were countersigned by the inter-
viewer or moderator.
Data
The transcripts of the focus group discussions and in-depth interviews in this study contain
sensitive information concerning people living with HIV as well as the clinics in which they
accessed care. The Human Research Ethics Committee (Medical) of the University of the Wit-
watersrand, Johannesburg, South Africa imposes ethical restrictions on sharing the data for
this study. However, data request may be sent to:
1. The Human Research Ethics Committee (Medical) of the University of the Witwatersrand,
Johannesburg, South Africa. Telephone: +27-11-717-1234, Fax: +27117171265.
2. Medical Research Council/ Wits Rural Public Health and Health Transitions Research Unit
(Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwa-
tersrand, Johannesburg, South Africa. Telephone: +27-11-717-2085 and + 27-13-795-5076
(Acornhoek), Fax: + 27-13-795-5076.
Fig 2. The 17 dimensions of quality of care and their intended structure, process and outcome constructs discussed in the focus groups and interviews in
2013. � The dimensions in red colour were the priority areas in the ICDM model.
https://doi.org/10.1371/journal.pone.0236270.g002
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Results
The viewpoints of service users and providers on HIV stigma (main theme), HIV testing and
reproductive health-related concerns (minor themes) are presented below. Verbatim quotes
reflecting the viewpoints of women and their running commentaries have been used to illus-
trate the main theme on HIV stigma and the subthemes on enacted, anticipated and internal-
ised domains of stigma. This was also applicable to the minor themes.
Socio-demographic characteristics of the study population
The number of FGD participants by gender is shown in Table 1. There were a total of 61 par-
ticipants: 43 females and 18 males. The higher number of female than male participants reflects
a high female: male ratio of 7:3 in an earlier population-based study in the setting [41] as well
as the facility-based study [33] from which the participants in this study were recruited. All the
seven facility managers were females aged 40 to 55 years.
Reduced HIV stigma in the health facilities
A facility manager, whose views represented that of many managers, reported that the ICDM
model of care reduced HIV stigma by other patients due to non-segregation of patients man-
aged for chronic diseases in the same clinic. This was because the former practice of segregat-
ing patients according to the illness they were being managed for made it easy to identify who
was receiving treatment for HIV/AIDS in the health facilities. This was corroborated in the
experience of service users where a woman described how she did not fear being identified as a
patient attending a follow-up clinic to receive anti-retroviral treatment because professional
nurses treated hypertension and diabetes patients as well as PLWH in the same consultation
room. This view was expressed by participants from some other health facilities.
Previously we were grouping them [patients] according to their diseases, but now they are put
together. Patients living with HIV/AIDS are satisfied because they are mixed with those who
are having hypertension and diabetes [IDI with Manager, Health Facility 6].
In the past, there used to be a separate clinic for HIV patients. But now, all of us (referring to
chronic disease patients) are getting our medication in one room. It is not easy for people
[referring to other patients] to say I am HIV positive [Respondent 1 (woman), FGD Health
Facility 5].
Table 1. Number of focus group discussion participants by gender.
Number of FGDs Gender Total
Female Male
FGD 1 4 3 7
FGD 2 4 3 7
FGD 3 6 2 8
FGD 4 7 2 9
FGD 5 6 2 8
FGD 6 7 2 9
FGD 7 5 3 8
FGD for defaulters 4 1 5
Total 43 18 61
https://doi.org/10.1371/journal.pone.0236270.t001
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Stigma in home-based care
Facility managers recounted how some community members stigmatised ill people who were
visited in their homes by home-based carers (HBCs). These community members were said to
have perceived persons visited by HBCs to have HIV/AIDS, and that these persons responded
by not allowing HBCs to visit their homes because they thought that HBCs divulged their per-
sonal information to some community members.
I told them not to come to my house any more. When I tell them something I expect them to
report it to their seniors not to tell the whole community [Respondent 5 (woman), FGD for
Health Facility 2].
Home-based carers are not accepted. They [those being visited at home] are thinking that
other people [community members] will think that they are HIV positive and that is why the
HBCs are not allowed to visit them at home [IDI with Manager, Health Facility 1].
Reproductive health-related stigmatisation by nurses
It was recounted in some FGDs how interactions between nurses and pregnant women living
with HIV who visited the facility to utilise antenatal care services showed an expectation that
women on ART should not get pregnant or should not desire to have children because of their
HIV positive status.
I gave my file that I am using to take treatment [referring to ART] and the other file for preg-
nancy [referring to antenatal care] and she [referring to a nurse] says: are you pregnant
again? She said it in a bad way. Then I asked her why she is talking like that and she said that
a person like me is not supposed to get pregnant. Then I said to her: if I am HIV positive, does
it mean I am not supposed to have children? I know my status and I know how to take care of
myself. I didn’t feel okay when she ask me that why am I pregnant. It means when a person is
positive she is not supposed to get pregnant? It means I am different from other people?
[Respondent 6 (woman) FGD for Health Facility 3].
Routine HIV testing as a barrier to contraceptive use and family planning
Respondents reported that young women who visited facilities for the purposes of receiving
contraceptives or family planning were compelled to take an HIV test, even though the
national contraception and family planning policy did not prescribe such practice. Young
women who refused to take an HIV test were denied access to contraceptives or family plan-
ning; hence, routine HIV testing was experienced as a barrier to uptake of reproductive health
services.
What I have observed is that, there are illnesses that you have to volunteer to be tested when
you go to the clinic. But when young women go to the clinic for contraceptives, they are forced
to test for HIV whether they like it or not. If you refuse to test you don’t get what you were
there for [Respondent 3 (woman), FGD for Health Facility 1].
Some participants in the FGDs recounted how young girls who were denied access to con-
traceptives because they refused to be tested for HIV by nurses in the health facilities were at
risk of getting pregnant.
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At the clinic, when they go for contraceptives, they [nurses] don’t give them [patients] without
testing for HIV. The young girls refuse to test and they will go home without getting the con-
traceptives. When you see lots of young women being pregnant, it is because they are afraid to
test for HIV. [Respondent 3 (woman) FGD for Health Facility 2].
HIV testing and disclosure of patients’ HIV status to family members
Respondents expressed views that HIV testing and disclosure of HIV status of a sick family
member would enable parents or caregivers to provide care and support services to ensure
adherence to medication. Furthermore, such disclosure could equip family members with the
knowledge to take preventive measures from being infected with HIV.
You find a person [family member] being told by the nurse that she has HIV, but she [patient]
will not tell the family that she is having HIV. She will get sicker and she will not tell you and
you will go around to the clinics and hospital trying to find a cure for her meanwhile she
knows what is killing her [Respondent 3 (woman) FGD for Health Facility 2].
I once went to the clinic with my cousin and she refused to be tested, I told her that she has to
test whether she likes it or not, and the nurses said to me that I must not force her because it’s
not according to the law. I told them that she is sick and I am the one to take care of her, how
am I going to do it without knowing what is eating her. So we have to fight them until they get
tested [Respondent 3 (woman) FGD for Health Facility 2].
Discussion
The main study finding showed convergent viewpoints of service users and providers on the
ICDM model being linked with reduced HIV stigma in the health facilities because patients
managed for HIV and NCDs were mixed together in the waiting and consultation rooms. On
the other hand, both service users and providers also had convergent perceptions of HIV stig-
matisation in the communities which were related to the recounted practices of HBCs visiting
the homes of people, some of who were PLWH, who missed their clinic appointments. Other
findings, from the viewpoints of service users, suggested that nurses expected women on ART
should not get pregnant because of their HIV status and conducted routine HIV testing of
non-pregnant young women who wanted to use contraceptives; hence, unwanted pregnancy
was an unintended consequence of non-use of contraceptives due to their refusal to take a rou-
tine HIV test. Finally, caregivers wanted HIV testing and/or disclosure of HIV status of sick
family members which they perceived was an enabler for them to support PLWH to adhere to
ART and to take preventive measures from being infected with HIV.
The pattern of HIV stigmatisation observed in this study is a paradox. On the one hand, the
ICDM model was linked with HIV stigma reduction in PHC facilities in the study setting, as
has been reported in Cambodia where HIV care was integrated with those for hypertension
and diabetes in designated hospitals [24]. However, the model was related to HIV stigmatisa-
tion in the communities, an unintended consequence of the ICDM model of care, where
HBCs traced persons managed for HIV or NCDs who defaulted from the clinics for the pur-
poses of linking them back to care. During such visits, community members identified the
homes visited by HBCs and perceived that the persons being visited were PLWH. This may
imply that the design of the community-based component of the ICDM model may not have
sufficiently addressed HIV stigmatisation at the community level. As shown elsewhere in
South Africa [42], a HIV stigma-reduction community hub intervention was successful in
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initiating the onset of changes in a community through the PLWH and people living close to
PLWH as community mobilisers active in the community hub to mobilise their own commu-
nities towards HIV stigma reduction through social change. Lessons learnt from this HIV
stigma-reduction community “hub” intervention could be useful in mobilising and educating
HBCs and community members towards HIV stigma reduction in the study setting.
Although the ICDM model of care was linked with reduced HIV stigma in the health facili-
ties, the perspective of service users was that enacted stigma still occurred among pregnant
HIV positive women who visited the antenatal clinic. These women felt stigmatised when
nurses told them they were not supposed to get pregnant because of their HIV status, and this
is expected. Although not in the context of the ICDM model, health worker-related stigma of
this nature has been reported in the provision of reproductive health care in Ilorin, Nigeria,
largely due to misperceptions [43]. On the other hand, a study in Lagos, Nigeria showed that
health workers were supportive of women living with HIV who wished to have babies [44]. In
Ghana, a study showed that a higher sexual and reproductive health stigma score was linked
with a history of pregnancy among adolescents [45]. These evidence suggest that health educa-
tion programmes should target health workers who offer reproductive health services to
address misperceptions for the purpose of providing a holistic service delivery in the context
of the ICDM model in South Africa and elsewhere. Aside stigma, the nurses may have genu-
inely intended for the pregnant women to have lower reproductive intention, which is linked
with HIV positive status. This has been reported in a study that used National Demographic
and Health Surveys to determine the effect of HIV status on fertility intention among women
in nine sub-Saharan African countries. The study showed that women who were HIV positive,
with knowledge of their status, had lower odds of wanting more children [46].
Anticipated and internalised stigmas were experienced by people in the communities when
HBCs visited their homes which were identifiable by community members. This could have
negative implications for activities of HBCs in implementing the community component of
the ICDM model. Lessons learned from a home-based intervention in southwestern Kenya
which led to enhanced couple HIV testing and counselling services and improved health out-
comes of pregnant women living with HIV [47] could be relevant in addressing HIV status dis-
closure in the HBC programme in the ICDM model used in South Africa.
Routine HIV testing for adolescents and young women in the study setting was perceived
to be a barrier to uptake of reproductive health services and contravened South Africa’s Chil-
dren’s Act [48]. Section 134 of the Act facilitates adolescents’ access to contraception with the
aim of preventing sexually active children� 12 years from contracting sexually transmitted
infections (including HIV) or falling pregnant [48]. Routine HIV testing, which is intended
for pregnant women, has its origin in the guideline on HIV testing established by the World
Health Organization (WHO) in 2004 [49]. The guideline recommends routine HIV testing for
all pregnancy-related visits by service providers, especially in high HIV transmission areas
with the intention of reducing mother-to-child HIV transmission. This study showed evidence
suggestive of health workers’ misapplication of the WHO guideline, through refusal to provide
contraceptives to adolescents who declined to take an HIV test, led to unintended conse-
quences such as unwanted pregnancy.
The WHO guidelines for HIV testing and counselling for adolescents living with HIV rec-
ommend early and full disclosure of HIV status of children of school age as this improves ART
adherence [50]. The findings of this study suggests that parents or guardians wanted routine
HIV testing and/or disclosures of the HIV status of their adolescent wards when they were ill.
Parents thought this would enable them to take preventive measures from being infected with
HIV, provide care and ensure adherence to ART. This is corroborated in a study in South
Africa that showed that early and full disclosure is strongly linked with improved adherence
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amongst ART-initiated adolescents 10–19 years of age; hence, disclosure may be an essential
tool in improving adolescent adherence and reducing mortality and onwards transmission
[51].
Although there has been changes in treatment guidelines and advances in model of care
after the data were collected in 2013, the findings of this study could still be of relevance in rec-
ommending policy and practice related to HIV stigma in the context of the ongoing nation-
wide scale-up of the ICDM model. This is because the way HIV stigma is viewed and
perceived by service users and facility managers in the ICDM model seven years afterward
may not have changed significantly.
The main strength of this study was that the use of a qualitative inquiry to explore HIV
stigma in the context of the ICDM model of care in South Africa was well suited for this
research; hence, the transferability of the findings to other African countries implementing the
ICDM model. Specifically, the knowledge generated from examining contextual factors that
promote or reduce HIV stigmatisation could have implications for recommending policies
and practices in the nationwide scale-up of the ICDM model. Furthermore, the viewpoints of
service users and providers on HIV stigma enhanced the robustness of the data generated to
fill the knowledge gap. Limitations do exist despite the aforementioned strengths of this study.
The findings of this study may not be generalised to the sub-population of chronic disease
patients receiving care in PHC facilities implementing the ICDM model elsewhere because the
study participants were recruited purposively, a non-probability sampling technique. Next,
this research was conducted in a rural setting and, therefore, its findings may not necessarily
reflect similar contextual factors in PHC facilities in urban and semi-urban areas where the
ICDM model is being implemented. Finally, the use of an inductive analytical approach only
and non-stratification of the FGDs by sex posed a limitation in this study. Although discus-
sions around HIV stigma was not anticipated at the time the study was designed, stratification
of the FGDs by sex could have been more appropriate in providing a gender-sensitive environ-
ment to elicit further discussions on lived experiences related to gender-specific HIV stigma.
Conclusions
Application of a comprehensive ICDM model was linked with reduced HIV stigma in the
health facilities, but was linked to stigmatisation in the communities. Routine HIV testing,
originally intended for pregnant women, of non-pregnant adolescents who desired to use con-
traceptives was related to unwanted pregnancies. Refusal to provide contraceptives to adoles-
cents who declined to take an HIV test could have far reaching implications for adolescent-
friendly reproductive health services. Caregivers of PLWH wanted routine HIV testing and/or
disclosures of the HIV status of their family members for the purposes of protecting their own
health and enhancing adherence to ART.
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